NIOX Group PLC - Asset Resilience Ratio
NIOX Group PLC (NIOX) has an Asset Resilience Ratio of 2.63% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See financial flexibility index of NIOX Group PLC to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2017)
This chart shows how NIOX Group PLC's Asset Resilience Ratio has changed over time. See NIOX net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down NIOX Group PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NIOX market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX10.00 Million | 2.63% |
| Total Liquid Assets | GBX10.00 Million | 2.63% |
Asset Resilience Insights
- Limited Liquidity: NIOX Group PLC maintains only 2.63% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
NIOX Group PLC Industry Peers by Asset Resilience Ratio
Compare NIOX Group PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Inspire Medical Systems Inc
NYSE:INSP |
Medical Devices | 20.29% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for NIOX Group PLC (2013–2017)
The table below shows the annual Asset Resilience Ratio data for NIOX Group PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 3.73% | GBX15.00 Million ≈ $1.83K |
GBX402.40 Million ≈ $48.96K |
0.00pp |
| 2017-12-30 | 3.73% | GBX15.00 Million ≈ $1.83K |
GBX402.40 Million ≈ $48.96K |
-2.26pp |
| 2016-12-31 | 5.99% | GBX20.00 Million ≈ $2.43K |
GBX334.10 Million ≈ $40.65K |
0.00pp |
| 2016-12-30 | 5.99% | GBX20.00 Million ≈ $2.43K |
GBX334.10 Million ≈ $40.65K |
-1.74pp |
| 2015-12-31 | 7.73% | GBX37.80 Million ≈ $4.60K |
GBX489.20 Million ≈ $59.52K |
0.00pp |
| 2015-12-30 | 7.73% | GBX37.80 Million ≈ $4.60K |
GBX489.20 Million ≈ $59.52K |
-70.53pp |
| 2014-12-31 | 78.25% | GBX156.90 Million ≈ $19.09K |
GBX200.50 Million ≈ $24.40K |
0.00pp |
| 2014-12-30 | 78.25% | GBX156.90 Million ≈ $19.09K |
GBX200.50 Million ≈ $24.40K |
+59.73pp |
| 2013-12-31 | 18.53% | GBX7.05 Million ≈ $857.42 |
GBX38.03 Million ≈ $4.63K |
0.00pp |
| 2013-12-30 | 18.53% | GBX7.05 Million ≈ $857.42 |
GBX38.03 Million ≈ $4.63K |
-- |
About NIOX Group PLC
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide … Read more